Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Tara M Babu"'
Autor:
Jeremy Stone, Richard A Mularski, Sarah N Cox, Mark A Schmidt, Helen Y Chu, Janet A Englund, Peter D Han, Caitlin R Wolf, Stephen P Fortmann, Sharon Saydah, Ning Smith, Marco Carone, Claire M Midgley, Allison L Naleway, Melissa Briggs-Hagen, Jennifer L Kuntz, Tara M Babu, Leora R Feldstein, Zachary Acker, Cassandra L Boisvert, Amanda Casto, Brenna Ehmen, Collrane J Frivold, Holly Groom, Tina Lockwood, Tara Ogilvie, Sacha L Reich, Lea Starita, Meredith Vandermeer, Ana A Weil
Publikováno v:
BMJ Open, Vol 13, Iss 7 (2023)
Introduction Although SARS-CoV-2 vaccines were first approved under Emergency Use Authorization by the Food and Drug Administration in late 2020 for adults, authorisation for young children 6 months to 6 months and adults aged
Externí odkaz:
https://doaj.org/article/48f1bd2538e241d28f084c1487abf866
Autor:
Angela R Branche, Nadine G Rouphael, Cecilia Losada, Lindsey R Baden, Evan J Anderson, Anne F Luetkemeyer, David J Diemert, Patricia L Winokur, Rachel M Presti, Angelica C Kottkamp, Ann R Falsey, Sharon E Frey, Richard Rupp, Martín Bäcker, Richard M Novak, Emmanuel B Walter, Lisa A Jackson, Susan J Little, Lilly C Immergluck, Siham M Mahgoub, Jennifer A Whitaker, Tara M Babu, Paul A Goepfert, Dahlene N Fusco, Robert L Atmar, Christine M Posavad, Antonia Netzl, Derek J Smith, Kalyani Telu, Jinjian Mu, Mat Makowski, Mamodikoe K Makhene, Sonja Crandon, David C Montefiori, Paul C Roberts, John H Beigel
Publikováno v:
Clinical Infectious Diseases.
In a randomized clinical trial, we compare early neutralizing antibody responses after boosting with bivalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines based on either BA.1 or BA.4/BA.5 Omicron spike p
Autor:
Angela R. Branche, Nadine G. Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer, David J. Diemert, Patricia L. Winokur, Rachel M. Presti, Angelica C. Kottkamp, Ann R. Falsey, Sharon E. Frey, Richard Rupp, Martín Bäcker, Richard M. Novak, Emmanuel B. Walter, Lisa A. Jackson, Susan J. Little, Lilly C. Immergluck, Siham M. Mahgoub, Jennifer A. Whitaker, Tara M. Babu, Paul A. Goepfert, Dahlene N. Fusco, Robert L. Atmar, Christine M. Posavad, Antonia Netzl, Derek J. Smith, Kalyani Telu, Jinjian Mu, Mat Makowski, Mamodikoe K. Makhene, Sonja Crandon, David C. Montefiori, Paul C. Roberts, John H. Beigel
Publikováno v:
medRxiv
In a randomized clinical trial, we compare early neutralizing antibody responses after boosting with bivalent SARS-CoV-2 mRNA vaccines based on either BA.1 or BA.4/BA.5 Omicron spike protein combined with wildtype spike. Responses against SARS-CoV-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b88c08987da7ee3b0952c4735903bfb8
https://europepmc.org/articles/PMC10081431/
https://europepmc.org/articles/PMC10081431/
Autor:
Tara M Babu, Sujatha Srinivasan, Amalia Magaret, Sean Proll, Helen Stankiewicz Karita, Jacqueline M Wallis, Stacy Selke, Dana Varon, Thepthara Pholsena, David Fredricks, Jeanne Marrazzo, Anna Wald, Christine Johnston
Publikováno v:
Open Forum Infectious Diseases. 10
BackgroundIn women, genital herpes simplex virus type 2 (HSV-2) infection is associated with increased risk for recurrent bacterial vaginosis (BV), but causal relationships are unclear.MethodsWomen with a self-reported history of BV and HSV-2 seropos
Autor:
Tara M. Babu, Leora R. Feldstein, Sharon Saydah, Zachary Acker, Cassandra L. Boisvert, Melissa Briggs-Hagen, Marco Carone, Amanda Casto, Sarah N. Cox, Brenna Ehmen, Janet A. Englund, Stephen P. Fortmann, Collrane J. Frivold, Holly Groom, Peter Han, Jennifer L. Kuntz, Tina Lockwood, Claire M. Midgley, Richard A. Mularski, Tara Ogilvie, Sacha Reich, Mark A. Schmidt, Ning Smith, Lea Starita, Jeremy Stone, Meredith Vandermeer, Ana A. Weil, Caitlin R. Wolf, Helen Y. Chu, Allison L. Naleway
IntroductionAlthough SARS-CoV-2 vaccines were first approved under Emergency Use Authorization by the FDA in late 2020 for adults, approval for young children 6 months to < 5 years of age did not occur until 2022. Understanding real world vaccine eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::868f3aae7006774c32ae1568149f7605
https://doi.org/10.1101/2023.01.05.22283913
https://doi.org/10.1101/2023.01.05.22283913
Autor:
Tara M Babu, R Scott McClelland, Christine Johnston, Stacy Selke, Dilpreet Singh, Jessica Moreno, Jina Taub, Morissa Pertik, Dana Varon, Thepthara Pholsena, Britt Murphy, Mark Drummond, Lindsey McClellan, Alyssa Braun, Matthew Seymour, Kirsten Hauge, Chris L McClurkan, Chloe Wilkens, Erin Goecker, Kerry J Laing, David M Koelle, Alexander L Greninger, Anna Wald
Publikováno v:
Open Forum Infectious Diseases. 9
Background In the United States, booster vaccines for persons 18 years and older were approved under Emergency Use Authorization (EUA) in September 2021. Waning immunity following SARS-CoV-2 primary vaccination series led to recommendations for boost
Autor:
Tara M Babu, Amanda M Casto, Jessica Heimonen, Yongzhe Wang Wang, Annie Emanuels, Eric J Chow, Samara Hoag, James Hughes, Constance E Ogokeh, Melissa A Rolfes, Timothy M Uyeki, Lea Starita, Janet A Englund, Helen Y Chu
Publikováno v:
Open Forum Infectious Diseases. 9
Background Families with children may be at higher risk for influenza infection. Community transmission can suffer from underreporting as testing is often not performed. We studied the epidemiology of influenza in households with school-aged children
Autor:
Camille N. Kotton, Tara M. Babu
Publikováno v:
Current Treatment Options in Infectious Diseases
Purpose of Review Infection is a significant cause of morbidity and mortality in both patients with chronic kidney disease (CKD) and in recipients of a kidney transplant (KT). We review the current data in patients with CKD, on dialysis, and in KT re
Autor:
Robert L, Atmar, Kirsten E, Lyke, Meagan E, Deming, Lisa A, Jackson, Angela R, Branche, Hana M, El Sahly, Christina A, Rostad, Judith M, Martin, Christine, Johnston, Richard E, Rupp, Mark J, Mulligan, Rebecca C, Brady, Robert W, Frenck, Martín, Bäcker, Angelica C, Kottkamp, Tara M, Babu, Kumaravel, Rajakumar, Srilatha, Edupuganti, David, Dobrzynski, Rhea N, Coler, Christine M, Posavad, Janet I, Archer, Sonja, Crandon, Seema U, Nayak, Daniel, Szydlo, Jillian A, Zemanek, Clara P, Dominguez Islas, Elizabeth R, Brown, Mehul S, Suthar, M Juliana, McElrath, Adrian B, McDermott, Sarah E, O'Connell, David C, Montefiori, Amanda, Eaton, Kathleen M, Neuzil, David S, Stephens, Paul C, Roberts, John H, Beigel, Todd, Haight
Publikováno v:
The New England journal of medicine. 386(11)
Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are highly effective, breakthrough infections are occurring. Data are needed on the serial use of homologous b
Autor:
Kirsten E. Lyke, Robert L. Atmar, Clara Dominguez Islas, Christine M. Posavad, Daniel Szydlo, Rahul PaulChourdhury, Meagan E. Deming, Amanda Eaton, Lisa A. Jackson, Angela Ramon Branche, Hana M. El Sahly, Christina Rostad, Judith M. Martin, Christine Johnston, Richard Rupp, Mark J. Mulligan, Rebecca C. Brady, Robert Frenck, Martin Bäcker, Angelica Kottkamp, Tara M. Babu, Kumaravel Rajakumar, Srilatha Edupuganti, David Dobrzynski, Rhea N. Coler, Janet I. Archer, Sonja Crandon, Jillian A. Zemanek, Elizabeth R. Brown, Kathleen M. Neuzil, David S. Stephens, Diane J. Post, Seema U. Nayak, Mehul Suthar, Paul C. Roberts, John H. Beigel, David C. Montefiori
Publikováno v:
SSRN Electronic Journal.